<html>
<head>
<title>Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19 • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">风投支持的 Celularity 获得 FDA 批准，对新冠肺炎的一种新细胞疗法进行早期试验 TechCrunch</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2020/04/02/venture-backed-celularity-receives-fda-approval-for-early-trials-of-a-new-cell-therapy-for-covid-19/amp/">https://web.archive.org/web/https://techcrunch.com/2020/04/02/venture-backed-celularity-receives-fda-approval-for-early-trials-of-a-new-cell-therapy-for-covid-19/amp/</a></blockquote><div><div class="content">

			
	
		
		

		
<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="Coronavirus structure" srcset="https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg 2077w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=150,104 150w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=300,208 300w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=768,534 768w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=680,472 680w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=1536,1067 1536w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=2048,1423 2048w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=1200,834 1200w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=50,35 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/b0b9f8d6ff32d1ae92d0321514880b97.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="Coronavirus structure" decoding="async" loading="lazy" srcset="https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg 2077w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=150,104 150w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=300,208 300w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=768,534 768w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=680,472 680w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=1536,1067 1536w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=2048,1423 2048w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=1200,834 1200w, https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?resize=50,35 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/GettyImages-1209871896.jpeg?w=1024"/> </noscript> </amp-img></p><p class="translated">图片来源:安德烈·奥努里延科/盖蒂图片社</p><p class="translated"><a href="https://web.archive.org/web/20230129062215/https://www.celularity.com/">癌症治疗新细胞疗法的风险投资开发商 Celularity </a>已经获得食品药品监督管理局的初步批准，开始对新冠肺炎的一种潜在疗法进行早期临床试验。</p>
<p class="translated">该公司迄今为止已经筹集了至少 2.9 亿美元(据<a href="https://web.archive.org/web/20230129062215/https://www.crunchbase.com/organization/celularity"> Crunchbase </a>报道)，使用“自然黑仔”(NK)细胞疗法来增强免疫系统的抗病反应。</p>
<p class="translated">就细胞增殖而言，这些 NK 细胞来自胎盘组织培养的干细胞，医院通常将其作为医疗废物处理。</p>
<p class="translated">由风险投资公司 Section 32 支持，战略投资者包括 Celgene，现在是百时美施贵宝的一个部门；生物医学技术开发商 United Therapeutics 人类长寿，由 j·克雷格·文特尔创立的陷入困境的风险投资创业公司；和 Sorrento Therapeutics，一家上市的生物医学公司，Celularity 正在寻求这种新型细胞疗法的一些应用，但其最初的重点是癌症治疗。</p>
<p class="translated">该公司真正的突破，也是它吸引如此多资本的原因之一，是它的细胞疗法不需要从患者捐赠者身上培养——这是一个漫长而昂贵的过程。Celularity 能够产生 NK 细胞并储存它们，以便在需要时可以随时输血。</p>
<p class="translated">该公司表示，随着 FDA 的批准，Celularity 将开始一项 86 人的小规模试验，以测试其 CYNK-001 免疫疗法治疗新冠肺炎感染成人的疗效。</p>
<p class="translated">在中国，至少有两项研究也在测试天然黑仔细胞是否可以用于治疗新冠肺炎。</p>
<p class="translated">NK 细胞是一种白细胞，是人体免疫系统的一部分。与针对特定病原体的 t 细胞不同，NK 细胞通常通过识别和破坏体内因感染或突变而出现应激的细胞来支持免疫系统。</p>
<p class="translated">这种疗法似乎可以成功治疗某些类型的癌症，该公司的研究人员推测，它可以在阻止新型冠状病毒的能力方面提供类似的结果，这种病毒导致新冠肺炎病毒在全身扩散。</p>
<p class="translated">然而，追求自然杀伤疗法有一些潜在的障碍和风险。首先，新冠肺炎是致命的，部分原因是它能让免疫系统超速运转。感染导致的“<a href="https://web.archive.org/web/20230129062215/https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext">细胞因子风暴</a>”意味着身体开始攻击肺部的健康细胞，导致器官衰竭和死亡。如果是这样的话，那么增强对新冠肺炎的免疫反应对患者来说可能是危险的。</p>
<p class="translated">还有一种可能性是，NK 细胞可能无法检测出哪些细胞感染了导致新冠肺炎的冠状病毒，从而导致治疗无效。</p>
<p class="translated">Celularity 的首席科学官萧岿·张在一份声明中说:“研究已经证实，无论是哪一种病毒，在病毒感染期间，NK 细胞都会被大量激活。”“这些功能表明，CYNK-001 可以通过消除受感染的细胞来限制新型冠状病毒复制和疾病进展，从而为新冠肺炎患者带来好处。”</p>
<p class="translated"><a href="https://web.archive.org/web/20230129062215/https://techcrunch.com/pages/covid-19-updates/"><amp-img src="https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/covid-19-footer.png" class="amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" layout="intrinsic" i-amphtml-layout="intrinsic"><i-amphtml-sizer class="i-amphtml-sizer"><img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/></i-amphtml-sizer><noscript><img decoding="async" src="../Images/ec1b457ff6c69f83ac05711152ccaa47.png" class="" data-original-src="https://web.archive.org/web/20230129062215im_/https://techcrunch.com/wp-content/uploads/2020/03/covid-19-footer.png"/></noscript></amp-img>T11】</a></p>


		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20230129062215im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
	<amp-pixel src="https://web.archive.org/web/20230129062215im_/https://pixel.wp.com/g.gif?v=ext&amp;blog=136296444&amp;post=1969236&amp;tz=-8&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>